ARL14: Potential Drug Target and Biomarker (G80117)

Target Name: ARL14

NCBI ID: G80117

ARL14

ARL14: Potential Drug Target and Biomarker

ARL14 (ARF7) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a part of the RNA-protein complex, known as the ribosomal subunit, that is responsible for the production of a variety of proteins in the cell.

One of the interesting things about ARL14 is its potential as a drug target or biomarker. The ARF7 protein has been shown to play a role in a variety of cellular processes, including cell signaling, DNA replication, and protein synthesis. As a result, ARL14 has been identified as a potential drug target for a variety of diseases.

One of the key benefits of ARL14 as a drug target is its high degree of cross-talk. ARL14 is expressed in many different tissues of the body, which means that it is likely to be involved in a wide range of physiological processes. This makes it an attractive target for drugs that can modulate its activity and have a beneficial effect on a variety of cellular processes.

In addition to its potential as a drug target, ARL14 has also been identified as a potential biomarker for a variety of diseases. For example, studies have shown that ARL14 is often elevated in the blood or urine of patients with a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. This suggests that ARL14 may be a useful diagnostic or prognostic marker for these diseases.

Another potential benefit of ARL14 as a drug target is its ability to be targeted with small molecules. Because ARL14 is expressed in many different tissues of the body, it is likely to be involved in a wide range of cellular processes. This makes it an attractive target for drugs that can inhibit its activity and have a therapeutic effect on a variety of cellular processes.

In addition to its potential as a drug target and biomarker, ARL14 is also of interest to researchers because of its unique structure and biology. The ARF7 protein is part of the RNA-protein complex, which is a complex structure that is responsible for the production of a variety of proteins in the cell. This means that ARL14 has a unique way of interacting with other proteins in the cell, which could be an attractive target for drugs that can modulate its activity.

Overall, ARL14 is a protein that has a lot of potential as a drug target or biomarker. Its high degree of cross-talk, its potential as a diagnostic or prognostic marker, its ability to be targeted with small molecules, and its unique structure and biology make it an attractive target for a variety of diseases. Further research is needed to fully understand the role of ARL14 in cellular processes and its potential as a drug or biomarker.

Protein Name: ADP Ribosylation Factor Like GTPase 14

Functions: GTPase that recruits MYO1E to MHC class II-containing vesicles via the effector protein ARL14EP and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells

The "ARL14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARL14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets